Picture this: Tuesday, 10 p.m. Your Slack channel lights up. A TikTok video claiming your GLP-1 trial “shrunk kidneys” has exploded from 200 to 20,000 shares while you were brushing your teeth. That familiar knot forms in your stomach. Sound familiar? Recently at Ticket-to-Biotech, Angela Dwyer (FullIntel’s Head of Insights) and I explored how biotech […]
